MENU
+Compare
CYDY
Stock ticker: OTC
AS OF
Nov 12 closing price
Price
$0.24
Change
-$0.00 (-0.00%)
Capitalization
314.38M

CYDY CytoDyn Inc. Forecast, Technical & Fundamental Analysis

CytoDyn Inc is a USA-based clinical-stage biotechnology company that focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection... Show more

CYDY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CYDY with price predictions
Nov 12, 2025

CYDY sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for CYDY moved below the 200-day moving average on November 04, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

CYDY moved below its 50-day moving average on October 16, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CYDY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CYDY broke above its upper Bollinger Band on October 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CYDY entered a downward trend on October 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 76 cases where CYDY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 12, 2025. You may want to consider a long position or call options on CYDY as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CYDY just turned positive on November 04, 2025. Looking at past instances where CYDY's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CYDY advanced for three days, in of 232 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (322.723).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CYDY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYDY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CYDY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1111 Main Street
Phone
+1 360 980-8524
Employees
12
Web
https://www.cytodyn.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SMBYX41.870.09
+0.22%
ClearBridge Mid Cap I
SCSIX43.190.07
+0.16%
Sterling Capital SmCp Val R6
RYRCX45.360.03
+0.07%
Rydex Retailing C
CTSIX47.030.01
+0.02%
Calamos Timpani Small Cap Growth I
PRJDX49.68-0.02
-0.04%
PGIM Jennison Global Opportunities R4

CYDY and Stocks

Correlation & Price change

A.I.dvisor tells us that CYDY and LVTX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYDY and LVTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYDY
1D Price
Change %
CYDY100%
-1.34%
LVTX - CYDY
32%
Poorly correlated
-0.62%
AGNPF - CYDY
24%
Poorly correlated
N/A
HUMA - CYDY
21%
Poorly correlated
-2.34%
GNMSF - CYDY
14%
Poorly correlated
+4.65%
BMNDF - CYDY
12%
Poorly correlated
N/A
More